Skip to main content
Livermore
Livermore
ZHEN

Versant Venture Management, LLC

SEC CIK
0001560009
Latest filing
Aug 12, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Versant Venture Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
148,831
Value
$8.12M
% of portfolio
5.0%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Versant Venture Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026148,831$8.12M5.0%00.0%UnchangedHolders
Q1 2026148,831$7.08M5.0%00.0%UnchangedHolders
Q4 2025148,831$7.80M5.2%00.0%UnchangedHolders
Q3 2025148,831$9.65M4.5%−349,727−70.1%ReducedHolders
Q2 2025498,558$24.2M29.5%00.0%UnchangedHolders
Q1 2025498,558$17.0M28.2%00.0%UnchangedHolders
Q4 2024498,558$19.6M22.6%00.0%UnchangedHolders
Q3 2024498,558$23.4M36.8%00.0%UnchangedHolders
Q2 2024498,558$26.9M34.8%00.0%UnchangedHolders
Q1 2024498,558$34.0M32.9%00.0%UnchangedHolders
Q4 2023498,558$31.2M8.0%00.0%UnchangedHolders
Q3 2023498,558$22.6M12.0%00.0%UnchangedHolders
Q2 2023498,558$28.0M33.2%00.0%UnchangedHolders
Q1 2023498,558$22.5M47.0%00.0%UnchangedHolders
Q4 2022498,558$20.3M41.9%00.0%UnchangedHolders
Q3 2022498,558$32.6M55.5%00.0%UnchangedHolders
Q2 2022498,558$30.3M46.4%00.0%UnchangedHolders
Q1 2022498,558$31.3M31.2%00.0%UnchangedHolders
Q4 2021498,558$37.8M20.2%00.0%UnchangedHolders
Q3 2021498,558$55.8M23.1%−10,000−2.0%ReducedHolders
Q2 2021508,558$82.3M27.3%−1,046,402−67.3%ReducedHolders
Q1 20211,554,960$189.5M36.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.